Ideas to action: independent research for global prosperity
Research
Innovative, independent, peer-reviewed. Explore the latest economic research and policy proposals from CGD’s global development experts.
POLICY PAPERS
April 15, 2024
WORKING PAPERS
April 15, 2024
CGD NOTES
April 11, 2024
WORKING PAPERS
April 11, 2024
All Research
Filters:
Experts
Facet Toggle
Topics
Facet Toggle
Publication Type
Facet Toggle
Time Frame
Facet Toggle
Research
CGD NOTES
March 15, 2024
The November guidance on RSF seems to have addressed some of the shortcomings observed in the initial RSF programs. However, as we highlight in this note, other deficiencies remain unresolved and require attention from the IMF’s Executive Board during the upcoming RSF review.
CGD NOTES
September 25, 2023
More than 190 countries have pledged under the 2015 Paris Agreement to reduce carbon emissions, including from fossil fuel consumption, by 2030 to avoid the negative effects of rising global temperatures. However, there is a large gap between what countries have committed to do and what needs to be ...
CGD NOTES
June 05, 2023
The World Bank’s lending function is important and irreplaceable. But providing countries with an important source of financing and investing in evidence do not have to be in tension. The role of evaluation should shift from an assessment function to one in which evaluation is a central tool of pro...
CGD NOTES
March 20, 2023
With global challenges high on the international agenda and financing set to increase in the coming years, a big push on evidence, backed by dedicated resources, is essential. This note makes the case for a reinvigorated evidence agenda to boost the impact of financing for development and global pub...
CGD NOTES
January 17, 2023
This CGD note summarizes the implications of the macroeconomic context and broader financing outlook for domestic and external health spending and proposes a “menu” of policy options to keep health spending on track and blunt negative impacts on health systems and population health around the world.
CGD NOTES
December 14, 2022
Almost a year after two oral antiviral treatments received emergency use authorization, demand is extremely low. In this note, we argue that governments and their donor partners should use data and evidence to consider the economic and clinical rationale for registering, financing, purchasing, and d...